Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: A Gynecologic Oncology Group Study

G. G. Fleming, V. L. Brunetto, D. Cella, K. Y. Look, G. C. Reid, A. R. Munkarah, R. Kline, R. A. Burger, A. Goodman, R. T. Burks, Paola A. Gehrig

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)205-207
Number of pages3
JournalWomen's Oncology Review
Volume4
Issue number3
DOIs
StatePublished - Sep 1 2004

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology
  • Cancer Research

Cite this

Fleming, G. G., Brunetto, V. L., Cella, D., Look, K. Y., Reid, G. C., Munkarah, A. R., Kline, R., Burger, R. A., Goodman, A., Burks, R. T., & Gehrig, P. A. (2004). Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: A Gynecologic Oncology Group Study. Women's Oncology Review, 4(3), 205-207. https://doi.org/10.1080/14733400412331312594